Summary
Overview
Work History
Education
Skills
Timeline
Generic
Spencer Hurst
Verified
This profile is verified using an email address.

Spencer Hurst

Houston,TX

Summary

Sales leader with a strong background in rare disease therapeutics, achieving remarkable growth metrics and national rankings. Expertise in institutional sales and product launches, complemented by a track record of enhancing stakeholder engagement at national account meetings. Dedicated to optimizing sales strategies that increase market access and elevate team performance.

Overview

16
16
years of professional experience

Work History

Institutional Business Manager

Azurity Pharmacueticals
Houston, TX
01.2026 - Current
  • Drastically outpaced all territories with 700% Danziten growth and 110% to goal with Vivimusta in Q1 2026 and ranked 3rd overall
  • Achieved 118% to goal with Danziten and 125% to goal with Vivimusta in Q2
  • Coordinated national account meetings and regional oncology conferences to enhance stakeholder engagement

Rare Disease - IBM

Azurity Pharmacueticals (Partnered with Eversana)
Houston, TX
06.2025 - 01.2026
  • Achieved first Danziten conversions in territory within 6 months of placement, establishing a new benchmark
  • Launched TKI Danziten in underachieving territory, increasing market presence
  • Promoting (TKI) Danziten – CML, (Bendamustine) Vivimusta - CLL

Senior Cardio-Renal-Metabolic Account Specialist

NOVARTIS
Houston, TX
03.2021 - 06.2025
  • Launched first-in-class injectable Leqvio for ASCVD patients, increasing access through outpatient infusion centers
  • Promoted Entresto (heart failure) and Leqvio (hypercholesterolemia)-small interfering RNA injectable
  • Achieved top 3% ranking among PCP representatives for market share growth nationally in 2022
  • Grew historically underperforming territory to top 10% nationally within one year
  • Achieved tiered promotion to enhance responsibilities to Senior Account Specialist June 2023
  • #1 in Region Q2,Q3 & Q4 2024
  • Ranked in top 7% in the nation for President's Club 2025

Direct Ortho Consultant

MEDACTA USA
Houston, TX
06.2019 - 07.2020
  • Grew underperforming territory to #1 in area earning 'Territory of the Year' with sales growth of 175% year over year in 2019
  • Recaptured $1.9M in lost revenue within one year through targeted recovery initiatives
  • Achieved top 15% national ranking in volume growth for Q1 2020
  • Oversaw operations at Houston Medical Center and satellite facilities, ensuring optimal service delivery

Senior Spine Consultant

AMG SURGICAL (Zimmer Biomet Spine Distributor)
Houston, TX
10.2018 - 06.2019
  • Spearheaded start-up territory, establishing and expanding Zimmer Biomet Spine brand presence in Texas Med Center (Baylor, UTHealth, Houston Methodist)
  • Converted 6 surgeons to Mobi-C Cervical Artificial Disc by Q2 2019, securing commitment for ongoing surgical cases
  • Developed educational programs for Texas Med Center residents and fellows to enhance knowledge of spine procedures

Direct Spine Consultant

MEDACTA USA
Houston, TX
04.2018 - 10.2018
  • Built relationships with 3 new surgeons within 90 days, expanding market share for Medacta Spine
  • Developed and implemented Medacta's first O.R. sales training program for new hires in Texas
  • Received Hot Shot Award for outstanding contributions in Q3

Lab Territory Manager, Dental Implant/Prosthetic Products

STRAUMANN
Houston, TX
12.2016 - 03.2018
  • Achieved $3.2M in territory revenue, reaching 120% of sales goal for 2017.
  • Developed sales platform that enhanced team members' call success, enabling quota exceedance for 2017.
  • Led sales initiatives in Texas and Louisiana markets, driving market growth.

Sales Representative, Spine Products

JOHNSON & JOHNSON, DEPUY SYNTHES SPINE
Austin, TX
12.2010 - 10.2016
  • Developed new accounts and nurtured relationships with surgeons across Nevada, Oregon, and Texas.
  • Coordinated communication among vascular, trauma, and general surgeons in operating room, enhancing surgical collaboration.
  • Grew business in a competitive market, achieving 117% to goal with $9.3M in sales 2015
  • Earned title of Regional Territory of the Year for outstanding achievements in 2014.
  • $7.2M in sales and 114% volume growth achieving #1 territory in area 2013
  • Honored as Region of the Year due to exceptional sales performance in 2011.
  • Surpassed sales goals by 136% in rookie year, achieving recognition for exceptional performance.

Education

Bachelor of Science (BS) - Multinational Business Operations

FLORIDA STATE UNIVERSITY
Tallahassee, FL

Skills

  • Institutional/Hospital Sales
  • Product Launches
  • Oncology
  • Hematology
  • Rare Disease
  • Neurology
  • Injectables
  • Specialty Therapeutics
  • Biopharmaceuticals
  • Specialty pharmacy
  • Market access
  • Buy and bill
  • Access & Reimbursement
  • Account Management
  • Commercial, Medicare, Medicaid
  • Relationship development

Timeline

Institutional Business Manager

Azurity Pharmacueticals
01.2026 - Current

Rare Disease - IBM

Azurity Pharmacueticals (Partnered with Eversana)
06.2025 - 01.2026

Senior Cardio-Renal-Metabolic Account Specialist

NOVARTIS
03.2021 - 06.2025

Direct Ortho Consultant

MEDACTA USA
06.2019 - 07.2020

Senior Spine Consultant

AMG SURGICAL (Zimmer Biomet Spine Distributor)
10.2018 - 06.2019

Direct Spine Consultant

MEDACTA USA
04.2018 - 10.2018

Lab Territory Manager, Dental Implant/Prosthetic Products

STRAUMANN
12.2016 - 03.2018

Sales Representative, Spine Products

JOHNSON & JOHNSON, DEPUY SYNTHES SPINE
12.2010 - 10.2016

Bachelor of Science (BS) - Multinational Business Operations

FLORIDA STATE UNIVERSITY
Spencer Hurst